This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Keppra XR

UCB SA

Drug Names(s): levetiracetam extended-release

Description: BioMedTracker has separate drug profiles for the IR and XR formulations of Keppra. Please also see Keppra IR.

All historical revenue for Keppra IR and Keppra XR is recorded under Keppra IR.

The precise mechanism(s) by which Keppra exerts its antiepileptic effect is unknown. Keppra binds to the SV2A synaptic vesicle protein. In an animal model, affinity for this protein has been correlated with anti-seizure activity, though its function has not definitively been established.


Keppra XR News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug